Sun Pharma bought the dip in its $11.7B Organon deal. Just not the right kind of dip (opens in new tab)

Organon’s Q1 numbers on 30 April showed how Sun bought its worst quarter. But India’s biggest pharma company will hope it doesn’t get worse before it gets better